BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20883638)

  • 1. Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance.
    Soto-Cardenas MJ; Perez-De-Lis M; Bove A; Navarro C; Brito-Zeron P; Diaz-Lagares C; Gandia M; Akasbi M; Siso A; Ballester E; Torres A; Ramos-Casals M
    Clin Exp Rheumatol; 2010; 28(5):647-53. PubMed ID: 20883638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.
    Ramos-Casals M; Sánchez-Tapias JM; Parés A; Forns X; Brito-Zerón P; Nardi N; Vazquez P; Vélez D; Arias I; Bové A; Plaza J; Rodés J; Font J
    J Rheumatol; 2006 Aug; 33(8):1593-9. PubMed ID: 16881116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
    Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
    Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young onset of primary Sjögren's syndrome: clinical and immunological characteristics.
    Ramos-Casals M; Cervera R; Font J; García-Carrasco M; Espinosa G; Reino S; Pallarés L; Ingelmo M
    Lupus; 1998; 7(3):202-6. PubMed ID: 9607645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ; Kelder JC
    Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
    Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
    Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Lung Disease Among Patients With Sjögren Syndrome: Frequency, Natural History, and Associated Risk Factors.
    Martínez-Balzano CD; Touray S; Kopec S
    Chest; 2016 Sep; 150(3):631-9. PubMed ID: 27231156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.
    Kobak S; Oksel F; Aksu K; Kabasakal Y
    Int J Rheum Dis; 2013 Feb; 16(1):88-92. PubMed ID: 23441777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
    Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
    J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
    Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
    Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
    Suresh L; Malyavantham K; Shen L; Ambrus JL
    BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.
    Katano K; Kawano M; Koni I; Sugai S; Muro Y
    J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.
    Brito-Zerón P; Gheitasi H; Retamozo S; Bové A; Londoño M; Sánchez-Tapias JM; Caballero M; Kostov B; Forns X; Kaveri SV; Ramos-Casals M
    Arthritis Res Ther; 2015 Sep; 17(1):250. PubMed ID: 26370711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Sjögren's syndrome in men: clinical and immunological characteristics.
    Cervera R; Font J; Ramos-Casals M; García-Carrasco M; Rosas J; Morlà RM; Muñoz FJ; Artigues A; Pallarés L; Ingelmo M
    Lupus; 2000; 9(1):61-4. PubMed ID: 10713648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
    Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.